These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 11371257)

  • 1. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes.
    El-Kebbi IM; Cook CB; Ziemer DC; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2003 Jan; 163(1):69-75. PubMed ID: 12523919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.
    Greenfield S; Billimek J; Pellegrini F; Franciosi M; De Berardis G; Nicolucci A; Kaplan SH
    Ann Intern Med; 2009 Dec; 151(12):854-60. PubMed ID: 20008761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.
    Petitti DB; Klingensmith GJ; Bell RA; Andrews JS; Dabelea D; Imperatore G; Marcovina S; Pihoker C; Standiford D; Waitzfelder B; Mayer-Davis E;
    J Pediatr; 2009 Nov; 155(5):668-72.e1-3. PubMed ID: 19643434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
    Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
    Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.
    Pandya BJ; Bron M; McCall T; Yu AP; Chen KS; Mattson ME; Wu EQ
    Curr Med Res Opin; 2011 Jan; 27(1):189-95. PubMed ID: 21142610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of casual postprandial glucose levels in type 2 diabetes management.
    El-Kebbi IM; Ziemer DC; Cook CB; Gallina DL; Barnes CS; Phillips LS
    Diabetes Care; 2004 Feb; 27(2):335-9. PubMed ID: 14747210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
    Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B
    J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of metabolic control in patients with type 2 diabetes].
    Kaznowska-Bystryk I; Goryńska A; Solski J
    Wiad Lek; 2011; 64(3):170-5. PubMed ID: 22335139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
    Craig ME; Jones TW; Silink M; Ping YJ
    J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
    Perusicová J; Haladová I; Pit'hová P; Acsová D; Belobrádková J; Belzová A; Berková K; Dolezalová B; Dvoráková H; Hejnicová K; Hudcová M; Kallmünzerová D; Krejsová Z; Markofová G; Müllerová H; Owen K; Pelikánová M; Raclavská L; Racická E; Skarpová O; Váchová A; Veselá A; Vyoralos J; Broz J; Edelsberger T; Honka M; Hrdina T; Chmura P; Tosovský J
    Vnitr Lek; 2013 Mar; 59(3):165-71. PubMed ID: 23713182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
    Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
    Aiello LP; Ayala AR; Antoszyk AN; Arnold-Bush B; Baker C; Bressler NM; Elman MJ; Glassman AR; Jampol LM; Melia M; Nielsen J; Wolpert HA;
    JAMA Ophthalmol; 2015 Aug; 133(8):888-96. PubMed ID: 25996273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.